A Prospective, Multicenter, Single Blind, Randomized, Controlled Japanese Population Trial Comparing MD02-LDCB Versus Standard Balloon Angioplasty for Treatment of Femoropopliteal Arteries
Latest Information Update: 07 Oct 2019
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial disorders
- Focus Therapeutic Use
- Acronyms LEVANT JAPAN
Most Recent Events
- 28 Sep 2019 According to a Becton, Dickinson and Company media release, independent analysis data from this and other two trials (LEVANT 2 and LEVANT I) and the Continued Access cohort of the LEVANT 2 trial were published in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions.
- 28 Sep 2019 According to a Becton, Dickinson and Company media release, independent analysis data from this and other two trials (LEVANT 2 and LEVANT I) and the Continued Access cohort of the LEVANT 2 trial were presented in in a late-breaking session at Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation.
- 27 Sep 2016 Status changed from active, no longer recruiting to completed.